Pharma Marketing Network

OCTOBER 3, 2024

In the digital age, content creation for social media has become an indispensable tool for industries across the board, including pharmaceuticals. As the healthcare landscape evolves, pharmaceutical companies are increasingly leveraging social media platforms to connect with healthcare professionals, patients, and the broader public.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication FDA 52

European Pharmaceutical Review

OCTOBER 10, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson has revealed that according to new safety data, SPRAVATO ® (esketamine nasal spray [NS]) has demonstrated superior efficacy compared to quetiapine extended-release (Quetiapine XR) for treatment-resistant depression (TRD).

Pharmaceutical Companies 109

Pharmaceutical Companies Pharmaceutical Companies Hospitals 109

PharmaShots

APRIL 25, 2023

Numerous pharmaceutical companies have developed and authorized vaccines to provide immunity against COVID-19. Despite the drenched market of covid products, many other drugs have set an impressive benchmark for pharmaceutical companies in 2021. Watch out for the full report on Dupixent tomorrow. Stay tuned!

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Vaccines Immunization 56

Pharma Mirror

OCTOBER 4, 2021

Despite untold investment by numerous pharmaceutical companies, FDA-approved drugs that target critical brain functions and conditions like anxiety, depression, and sedation continue to present severe and unpredictable side effects, including suicidal ideation.

Pharmaceutical Companies 119

Pharmaceutical Companies Pharmaceutical Companies FDA 119

InCrowd

FEBRUARY 2, 2023

Learn how InCrowd helped one pharmaceutical company track data shared at last year’s Annual Meeting of the European Society for Medical Oncology (ESMO 2022) in just 72 hours. The company sought to: Explore which tumor type/track had the most exciting data presented at ESMO 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

JANUARY 12, 2024

A key producer of innovative medicines: increasing manufacturing capacity Boehringer Ingelheim’s facility in Koropi is the only industrial facility of a multinational pharmaceutical company in Greece producing innovative medicines, the company acknowledged.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Pharma Marketing Network

JULY 26, 2023

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled. However, in recent years, there has been a noticeable decline in the number of these letters being issued.

FDA 97

FDA Pharmaceutical Companies Pharmaceutical Companies Labelling 97

European Pharmaceutical Review

SEPTEMBER 15, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson has changed its name to Johnson & Johnson Innovative Medicine (J&J Innovative Medicine). Johnson & Johnson is bringing together its divisions under the J&J brand name.

Chemotherapy 98

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Packaging 98

Pharma Marketing Network

MAY 15, 2023

With the advent of electronic health records, social media, and other digital sources, pharmaceutical companies now have access to vast amounts of data that can be used to inform their marketing strategies. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

European Pharmaceutical Review

AUGUST 31, 2023

[pharmaceutical companies] must take measures to manage antibiotic waste across the manufacturing supply chain” 2023 has so far, delivered a spectrum of change for antibiotic manufacturers across the pharmaceutical industry, from supply chain issues through to regulatory opportunities.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Hospitals 97

Pharma Marketing Network

MARCH 23, 2023

With the advent of electronic health records, social media, and other digital sources, pharmaceutical companies now have access to vast amounts of data that can be used to inform their marketing strategies. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

MARCH 27, 2023

The results from Janssen’s ESCAPE-TRD Phase IIIb trial presented at the European Congress of Psychiatry (EPA) 2023 indicated that esketamine NS achieved significantly higher remission rates from Week 6 and response rates as early as Day 15 in the study. percent versus 39.1 percent for quetiapine XR.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies 103

European Pharmaceutical Review

OCTOBER 20, 2023

The first readout of two-year data from the ADjoin long-term extension study is being presented at the 2023 Annual Fall Clinical Dermatology Conference. This cytokine drives the type-2 inflammatory loop in the skin, which leads to skin barrier dysfunction, itch, skin thickening and infection.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Viseven

MAY 15, 2023

Pharmaceutical detailing is the most time-tested marketing format in the medical content world. Old-timer sales reps should remember how pharmaceutical companies reckoned face-to-face (F2F) visits with doctors as the most effective approach to achieving their sales targets. What is Pharmaceutical Detailing?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Patient Care 52

European Pharmaceutical Review

APRIL 8, 2024

A study investigating the trend for existing pharmaceutical companies to outsource to contracted development and manufacturing organisations (CDMOs), analysing the position of companies manufacturing monoclonal antibody drugs (mAbs). Yoshiura et al. Yoshiura et al.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding 52

The FDA Law Blog

MARCH 6, 2024

His presentation will focus on “MoCRA is Here – Now What? His practice supports clients throughout the life sciences from biotech startups and multinational pharmaceutical companies to CROs and academic researchers to patient advocacy organizations. On March 20-21, Counsel John W.M.

FDA 57

FDA Pharmaceutical Companies Pharmaceutical Companies 57

Viseven

AUGUST 15, 2024

In an era where medicine is rapidly becoming more personalized, why do pharmaceutical companies still struggle to effectively engage with the very individuals they aim to serve? Additionally, the COVID-19 pandemic has intensified public scrutiny of pharmaceutical companies, creating a unique opportunity to build trust with patients.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Packaging 52

Pharma Marketing Network

MAY 3, 2023

The FDA has strict guidelines for what information can be included in drug advertisements and how it should be presented to the public. To ensure that they are in compliance with the regulatory environment, pharmaceutical companies must have a thorough understanding of the FDA and FTC regulations.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

Pharma Marketing Network

OCTOBER 14, 2024

These technologies enable pharmaceutical companies to analyze vast amounts of data quickly, identify potential drug candidates, and optimize clinical trials, ultimately accelerating the time-to-market for new therapies. Partnerships and collaborations are gaining traction as innovative marketing strategies in the pharma industry.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

pharmaphorum

JUNE 25, 2020

COVID-19 has brought many changes to the pharmaceutical industry, among them a need to change how pharma companies engage with HCPs and transform their approach to digital channels.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

AUGUST 3, 2023

.” Implementing quality standards for medicinal cannabis Mikael Sodergren of Curaleaf International explained in an article published on EPR’s website last month: “there is a vast range of flavonoids, terpenoids, phytols and other compounds present at lower concentrations within the cannabis flower”.

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

SEPTEMBER 21, 2023

Higher efficiency tralokinumab drug delivery Tralokinumab is at present, available in a 150mg in 1 mL pre-filled syringe, requiring four initial, and two maintenance doses with the 150mg in 1mL pre-filled syringe. It inhibits interaction with the IL-13 receptor α1 and α2 subunits (IL-13Rα1 and IL-13Rα2).

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Immunization 105

ISPE

JUNE 23, 2023

Presentations will discuss harmonized approaches to advancements in drug development, design and equipment solutions, and project delivery strategies to ensure that quality therapeutic products are brought to market in an efficient and sustainable manner to improve patient health.

Pharmaceutical Companies 94

Pharmaceutical Companies Pharmaceutical Companies 94

European Pharmaceutical Review

DECEMBER 21, 2023

Using 38 amino acids as a test class of molecules, the utility of carbonated liquids as a green alternative was presented at speeds, efficiencies and resolutions never reported,” Armstrong said. The UTA study corrected the original AMGS equation and extended it to cover more realistic separations including chiral amino acids.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

ISPE

NOVEMBER 2, 2022

Applying what has been learned over the last three years to update pharmaceutical companies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. President, U.S. Business Unit and U.S. Country Head. Cognizant Technology Solutions.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

InCrowd

APRIL 30, 2024

Awareness and impact of new clinical data/presentation sessions. Attendance and oncologist-preferred methods of interaction with pharmaceutical companies Get in touch to learn how you can leverage InCrowd’s expertise to navigate ASCO 2024 and shape the future of cancer care.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

The Checkup by Singlecare

DECEMBER 1, 2022

In order to test, market, and release drugs onto the market, pharmaceutical companies must abide by government regulations and oversight processes. . Regulatory affairs, however, encompasses more than just the pharmaceutical industry. Pharmacists who work in the private sector typically work for a pharmaceutical company.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 98

European Pharmaceutical Review

AUGUST 9, 2023

The REMIX data for Novartis’ novel BTK inhibitor will be presented at an upcoming medical meeting. The pharmaceutical company announced that it plans to submit to global health authorities in 2024. There were 470 participants in the REMIX-1 study. In REMIX-2, the clinical trial enrolled 455 participants with CSU.

Immunization 94

Immunization Pharmaceutical Companies Pharmaceutical Companies 94

European Pharmaceutical Review

JANUARY 3, 2023

A marketing authorisation application (MAA) has been submitted by The Janssen Pharmaceutical Companies of Johnson & Johnson to the European Medicines Agency (EMA) for approval of talquetamab, a bispecific t-cell engager antibody for the treatment of patients with relapsed or refractory multiple myeloma (RRMM).

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

Pharmafile

MARCH 6, 2023

Published date: 06/03/2023 Summary: Study findings presented during the American College of Cardiology’s 72nd Annual Scientific Session & Expo Together With World Heart Federation’s World Congress of Cardiology European Society of Cardiology/European Respiratory Society (ESC/ERS) PH guidelines recommend initial dual combination therapy with macitentan (..)

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40

European Pharmaceutical Review

AUGUST 10, 2023

Janssen Pharmaceutical Companies of Johnson & Johnson’s first-in-class bispecific T-cell engaging antibody showed an overall response rate (ORR) of over 70 percent in heavily pre-treated multiple myeloma. The post Multiple myeloma bispecific antibody granted accelerated approval appeared first on European Pharmaceutical Review.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

European Pharmaceutical Review

MARCH 28, 2023

At present, the pharmaceutical company has a manufacturing campus in Kinsale and a Global Business Solutions Centre in Little Island, Cork. The IDA noted that the jobs will cover areas including engineering, scientists, and operations. In May 2022 , the firm declared it planned to put a $2.1

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies 95

Pharma Marketing Network

OCTOBER 17, 2023

Benefits of Chatbots in Pharma Chatbots offer a number of benefits to pharmaceutical companies. Finally, chatbots can be used to gather customer feedback and insights, which can help pharmaceutical companies improve their products and services.

Customer Service 40

Customer Service Pharmaceutical Companies Pharmaceutical Companies 40

Viseven

JULY 10, 2024

Medical writers, thus, serve as key intermediaries between researchers, pharmaceutical companies, and the broader medical community. That’s why medical writers, whether they’re crafting promotional materials for pharmaceutical companies or penning articles for medical journals, need to be spot-on with their words.

Communication 52

Communication Documentation Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

NOVEMBER 24, 2022

Citing people close to the matter, Bloomberg suggests that Mirati is the subject of takeover interest from “large pharmaceutical companies” and has been weighing up its “strategic options” including a possible sale, although it does say that no formal bids are on the table and a deal is not imminent.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies FDA 105

pharmaphorum

JANUARY 4, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson have submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA), seeking approval of talquetamab for the treatment of patients with relapsed or refractory multiple myeloma (RRMM). mg/kg dose and 73% at a 0.8

FDA 94

FDA Pharmaceutical Companies Pharmaceutical Companies 94

Pharma Marketing Network

AUGUST 9, 2023

Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.

Packaging 52

Packaging Labelling Communication Pharmaceutical Companies 52